Evidence map›Paper›PMID 22752343›Full record

ArticleJournal of clinical immunology2012

A missense mutation in the extracellular domain of Fas: the most common change in Argentinean patients with autoimmune lymphoproliferative syndrome represents a founder effect.

María Gabriela Simesen de Bielke, Judith Yancoski, Carlos Rocco, Laura E Pérez, Claudio Cantisano, Néstor Pérez, Matías Oleastro, Silvia Danielian

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).Clinical reviews in allergy & immunology · 2016
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

María Gabriela Simesen de BielkeServicio de Inmunología y Reumatología, Hospital de Pediatría J. P. Garrahan, Buenos Aires, Argentina.
Judith Yancoski
Carlos Rocco
Laura E Pérez
Claudio Cantisano
Néstor Pérez
Matías Oleastro
Silvia Danielian
Garrahan Hospital · ARHospital de Niños Superiora Sor María Ludovica · ARHospital Pedro de Elizalde · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledMutations in the Fas gene (TNFRSF6) are the most common causes of Autoimmune Lymphoproliferative Syndrome (ALPS-FAS). PURPOSE: In Argentina almost a third of patients with ALPS-FAS present a missense mutation affecting the extracellular cysteine rich domain 2 of Fas, p.Cys107Tyr (C107Y). This change was found in homozygous state in 2 patients from a consanguineous family, and heterozygously, in 3 other patients from 3 unrelated families. In these families, 12 relatives were identified as healthy carriers of the mutation. We sought to test the hypothesis that this mutation actually represents a single haplotype of TNFRSF6.

methodsDNAs from ALPS-C107Y patients and their families, as well as from 150 Argentinean control subjects were sequenced for the known higher frequency single nucleotide polymorphisms (SNPs) of TNFRSF6. The C107Y-carriers were also genotyped at 5 microsatellites proximal to the Fas gene locus.

resultsAll C107Y alleles presented a unique intragenic haplotype that could be restricted to this group. Extent of haplotype sharing and variability of microsatellite alleles in C107Y chromosomes support the presence of a single haplotype block including the mutation and encompassing 2.395 Mb.

conclusionsA founder effect for C107Y has been evidenced in this work and the most common recent ancestor to the patients probably lived 350 years ago. This constitutes the first report of a founder event in ALPS.

Indexed as

Founder EffectMutation, MissensePolymorphism, Single NucleotideAdolescentAdultAllelesArgentinaAutoimmune Lymphoproliferative SyndromeBase SequenceCase-Control StudiesChildfas ReceptorFemaleHaplotypesHeterozygoteHomozygoteFAS protein, humanfas Receptor

Identifiers

PMID22752343
OpenAlexW2072132340

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.